Understanding Stomach Ulcers and Blood Profile Changes
Abstract
Peptic ulcers are a common gastrointestinal condition causing inflammatory damage to the stomach or duodenal mucosa, extending into deeper tissue layers. Symptoms range from mild abdominal pain to severe bleeding and perforation. This article provides a detailed overview of peptic ulcers, including types, symptoms, defense mechanisms of the gastric mucosa, and treatment options. It also examines the impact of peptic ulcers on blood composition, revealing significant changes. The study highlights a knowledge gap in understanding the full systemic effects of peptic ulcers. The research aims to elucidate these effects using a comprehensive review and analysis. Results indicate that peptic ulcers significantly affect blood and gland physiology, suggesting the need for preventative measures and targeted treatments to manage this complex condition. Implications of these findings underscore the importance of avoiding contributing factors to prevent associated illnesses and improve treatment efficacy.
References
Kolumbus.fi, "Gastrolab," pp. 97-101, 2014.
M. Narayanan, K. M. Reddy, and E. Marsicano, "Peptic Ulcer Disease and Helicobacter pylori Infection," *Missouri Medicine*, vol. 115, no. 3, pp. 219-224, May-Jun. 2018.
A. Augustyn, "Stomach Anatomy," Jan. 6, 2020. [Online]. Available: https://www.britannica.com/science/stomach
Mayo Clinic, "Peptic Ulcer," Aug. 6, 2020. [Online]. Available: https://www.mayoclinic.org/ar/diseases-conditions/peptic-ulcer/symptoms-causes/syc-20354223
D. Bandyopadhyay, K. Biswas, M. Bhattacharyya, R. J. Reiter, and R. K. Banerjee, "Gastric Toxicity and Mucosal Ulceration Induced by Oxygen-Derived Reactive Species, Protection by Melatonin," *Current Molecular Medicine*, vol. 1, pp. 501-513, 2001.
W. Leslie, "Peptic Ulcer: A Reappraisal of Its Peptic Aetiology," *Annals of the Royal College of Surgeons of England*, vol. 50, pp. 146-163, 1972.
S. Bhat, *SRB's Manual of Surgery*, p. 364, 2013.
C. S. Crispian and R. S. Rosemary, "Mouth Ulcers and Other Causes of Orofacial Soreness and Pain," *British Medical Journal*, vol. 321, pp. 162-165, 2000.
T. S. I. Tilliss and J. D. McDowell, "Differential Diagnosis: Is It Herpes or Aphthous?" *Journal of Contemporary Dental Practice*, vol. 1, pp. 001-015, 2002.
C. Scully and S. R. Porter, "Recurrent Aphthous Stomatitis: Current Concepts of Etiology, Pathogenesis and Management," *Journal of Oral Pathology and Medicine*, vol. 18, pp. 21-27, 1989.
T. Axell and V. Henricsson, "Association Between Recurrent Aphthous Ulcers and Tobacco Habits," *Scandinavian Journal of Dental Research*, vol. 93, pp. 239-242, 1985.
M. A. Al-Mofarreh and I. A. Al Mofleh, "Esophageal Ulceration Complicating Doxycycline Therapy," *World Journal of Gastroenterology*, vol. 9, pp. 609-611, 2003.
D. Majumdar, J. Bebb, and J. Atherton, "Helicobacter pylori Infection and Peptic Ulcers," *Medicine*, vol. 39, pp. 154-161, 2011.
L. B., E. S., A. G. Van D. V., R. R., A. C., et al., "Helicobacter Pylori Cytotoxin-Associated Gene A Subverts the Apoptosis-Simulating Protein of p53 ASPP2 Tumor Suppressor Pathway of the Host," 2011, pp. 1-6.
M. Akram, S.-U. Shahab, A. Ahmed, K. Usmanghani, A. Hannan, E. Mohiuddin, et al., "Peptic Ulcer and Helicobacter pylori Eradication: A Review Article," *International Journal of Medical Sciences*, vol. 2, pp. 370-375, 2010.
S. Szabo, A. Vincze, Z. Sandor, M. Jadus, Z. Gombos, A. Pedram, et al., "Vascular Approach to Gastroduodenal Ulceration. New Studies with Endothelins and VEGF," *Digestive Diseases and Sciences*, vol. 43, pp. 40-45, 1998.
T. Aihara, E. Nakamura, K. Amagase, K. Tomita, T. Fujishita, K. Furutani, et al., "Pharmacological Control of Gastric Acid Secretion for the Treatment of Acid-Related Peptic Disease: Past, Present, and Future," *Pharmacology and Therapeutics*, vol. 98, pp. 109-127, 2003.
C. Tasman-Jones, "Pathogenesis of Peptic Ulcer Disease and Gastritis: Importance of Aggressive and Cytoprotective Factors," *Scandinavian Journal of Gastroenterology*, vol. 21, pp. 1-5, 1986.
J. B. Martin, "Not All Helicobacter pylori Strains Are Created Equal; Should All Be Eliminated?" *Lancet*, vol. 349, pp. 1020-1022, 1997.
X. G. Fan, D. Kelleher, X. J. Fan, H. X. Xia, and P. W. Keeling, "Helicobacter pylori Increases Proliferation of Gastric Epithelial Cells," *Gut*, vol. 38, pp. 19-22, 1996.
B. Marshall and J. R. Warren, "Unidentified Curved Bacillus in Active Chronic Gastritis," *Lancet*, vol. 1, p. 1, 1983.
E. Lindstrom, D. Chen, P. Norlen, K. Andersson, and R. Hakanson, "Control of Gastric Acid Secretion: The Gastrin-ECL Cell-Parietal Cell Axis," *Comparative Biochemistry and Physiology A Molecular and Integrative Physiology*, vol. 128, pp. 505-514, 2001.
T. Terence and R. Enrique, "CCK2 Receptor Mediates Rapid Protein Kinase D Activation Through a Protein Kinase C-Dependent Pathway," *FEBS Letters*, vol. 489, pp. 101-106, 2001.
H. L. Waldum, P. M. Kleveland, A. K. Sandvik, E. Brenna, U. Syversen, I. Bakke, and K. Tommeras, "The Cellular Localization of the Cholecystokinin 2 Receptor in the Stomach," *Pharmacology and Toxicology*, vol. 91, pp. 359-362, 2002.
B. L. Hunyady, A. R. Z. Lyomi, B. J. Hoffman, and E. V. Mezey, "Gastrin-Producing Endocrine Cells: A Novel Source of Histamine in the Rat Stomach," *Endocrinology*, vol. 139, pp. 4404-4415, 1998.
A. K. Sandvik, P. M. Kleveland, and H. L. Waldum, "Muscarinic M2 Stimulation Releases Histamine in the Totally Isolated, Vascularly Perfused Rat Stomach," *Scandinavian Journal of Gastroenterology*, vol. 23, pp. 1049-1056, 1988.
M. R. Griffin, J. M. Piper, J. R. Daugherty, M. Snowden, and W. A. Ray, "Nonsteroidal Anti-Inflammatory Drug Use and Increased Risk for Peptic Ulcer Disease in Elderly Persons," *Annals of Internal Medicine*, vol. 114, pp. 257-263, 1991.
C. Scarpignato and R. H. Hunt, "Nonsteroidal Anti-Inflammatory Drug-Related Injury to the Gastrointestinal Tract: Clinical Picture Pathogenesis, and Prevention," *Gastroenterology Clinics of North America*, vol. 39, pp. 433-464, 2010.
J. R. Vane and R. M. Botting, "Mechanism of Action of Nonsteroidal Anti-Inflammatory Drugs," *American Journal of Medicine*, vol. 104, pp. 2S-8S, 1998.
B. J. R. Whittle, "Gastrointestinal Effects of Nonsteroidal Anti-Inflammatory Drugs," *Fundamental and Clinical Pharmacology*, vol. 17, pp. 301-313, 2002.
A. Allen, G. Flemstrom, A. Garner, and E. Kivilaakso, "Gastroduodenal Mucosal Protection," *Physiological Reviews*, vol. 73, pp. 823-857, 1993.
L. D. Nedelcu, V. Grapa, P. Sandor, and D. L. Orbai, "Inhibition of Reserpine-Induced Ulcers by Calcitonin in Rats," *Bulletin of the Transilvania University of Brasov Series VI: Medical Sciences*, 2011.
Y. Tache, E. Kolve and L. Yang, "Central Neural Regulation of Gastric Acid Secretion: A Role for Corticotropin-Releasing Factor," *Digestive Diseases and Sciences*, vol. 34, pp. 71-78, 1989.
P. H. Guth, "Current Concepts in Gastric Microcirculatory Pathophysiology," *Yale Journal of Biology and Medicine*, vol. 64, pp. 575-590, 1991.
G. T. Meric, A. Melih, and C. Y. Sevgi, "Helicobacter pylori: the Agent of a Necessary Journey," *Biomedical Papers*, vol. 145, pp. 53-64, 2001.
J. R. Spencer and R. B. Langer, "Protein Digestion and Absorption in the Human Small Intestine," *Journal of Physiology and Pharmacology*, vol. 61, pp. 183-186, 2010.
B. Alarcon de la Lastra, A. Motilva, and M. J. Herrerias, "Gastrointestinal Damage Induced by Non-Steroidal Anti-Inflammatory Drugs: An Update," *Digestive Diseases and Sciences*, vol. 42, pp. 155-173, 2000.
Y. T. Lin and T. T. Chen, "Role of Endogenous Nitric Oxide in Gastric Acid Secretion," *American Journal of Physiology*, vol. 273, pp. G832-G840, 1997.
C. I. Lee and S. H. Lee, "H. pylori Infection and Reflux Esophagitis," *Korean Journal of Gastroenterology*, vol. 58, pp. 111-116, 2011.
J. M. Danesh, "Helicobacter pylori Infection and Serum Ferritin Concentration," *Gastroenterology*, vol. 113, pp. 675-679, 1997.
A. Uehara, T. Okumura, C. Sekiya, K. Okamura, Y. Takasugi, and M. Namiki, "Interleukin-1 inhibits the secretion of gastric acid in rats: possible involvement of prostaglandin," *Biochem Biophys Res Commun*, vol. 162, pp. 1578–1584, 1989.
K. K. Wu, R. Sanduja, A. L. Tsai, B. Ferhanoglu, and D. S. Loose-Mitchell, "Aspirin inhibits interleukin 1-induced prostaglandin H synthase expression in cultured endothelial cells," *Proc Natl Acad Sci U S A*, vol. 88, pp. 2384–2387, 1991.
M. M. Batool, "Some cytokines profile in gastric ulcer," *N Iraqi J Med*, vol. 7, pp. 33-37, 2011.
K. Takeuchi, T. Ohuchi, and S. Okabe, "Effects of nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester on duodenal alkaline secretory and ulcerogenic responses induced by mepirizole in rats," *Dig. Dis. Sci*, vol. 40, pp. 670–677, 1995.
S. Szabo and A. Vincze, "Growth factors in ulcer healing: lessons from recent studies," *J Physiol Paris*, vol. 94, pp. 77–81, 2000.
J. P. Maloney, C. C. Silliman, D. R. Ambruso, J. Wan, R. M. Tuder, and N. F. Voelkel, "In vitro release of vascular endothelial growth factor during platelet aggregation," *Am J Physiol Heart Circ Physiol*, vol. 275, pp. H1054–H1061, 1998.
B. Berse, L. F. Brown, L. Van de Water, H. F. Dvorak, and D. R. Senger, "Vascular permeability factor gene is expressed differentially in normal tissues, macrophages, and tumors," *Mol Biol Cell*, vol. 3, pp. 211–220, 1992.
M. K. Jones, H. Kawanaka, D. Baatar, I. L. Szabo, R. Tsugawa Pai, G. Y. Koh, I. Kim, J. Sarfeh, and A. S. Tarnawski, "Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEGF and angiopoietin-1," *Gastroenterology*, vol. 121, pp. 1040–1047, 2001.
J. L. Wallace and M. J. Miller, "Nitric oxide in mucosal defense: a little goes a long way," *Gastroenterology*, vol. 119, pp. 512–520, 2000.
J. Bilski, P. C. Konturek, S. J. Konturek, M. Cieszkowski, and K. Czarnobilski, "Role of endogenous nitric oxide in the control of gastric acid secretion, blood flow and gastrin release in conscious dogs," *Regul Pept*, vol. 53, pp. 175–184, 1994.
B. Whittle, J. Lopez-Belmonte, and S. Moncada, "Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat," *Br J Pharmacol*, vol. 99, pp. 607–611, 1990.
W. K. MacNaughton, G. Cirino, and J. L. Wallace, "Endothelium-derived relaxing factor has protective actions in the stomach," *Life Sci*, vol. 45, pp. 1869–1876, 1989.
M. J. Miller and M. Sandoval, "Nitric oxide: III. A molecular prelude to intestinal inflammation," *Am J Physiol*, vol. 276, pp. G795–G799, 1999.
L. Ma and J. L. Wallace, "Endothelial nitric oxide synthase modulates gastric ulcer healing in rats," *Am. J Physiol Gastrointest. Liver Physiol*, vol. 279, pp. G341-G346, 2000.
T. Takeuchi, S. Miura, L. Wang, K. Uehara, M. Mizumori, H. Kishikawa, et al., "Nuclear Factor- B and TNF- Mediate Gastric Ulceration Induced by Phorbol Myristate Acetate," *Dig Dis Sci*, vol. 47, pp. 2070-2078, 2002.
E. Mannick, L. E. Bravo, G. Zarama, J. L. Realpe, X. J. Zhang, B. Ruiz, et al., "Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants," *Cancer Res*, vol. 56, pp. 3238-3243, 1996.
C. S. Freitas, C. H. Baggio, J. E. Da Silva-Santos, L. Rieck, C. A. de Moraes Santos, et al., "Involvement of nitric oxide in the gastroprotective effects of an aqueous extract of Pfaffia glomerata Pedersen, Amaranthaceae, in rats," *Life Sci*, vol. 74, pp. 1167-1179, 2004.
S. Kato, M. Kitamura, R. P. Korolkiewicz, and K. Takeuchi, "Role of nitric oxide in regulation of gastric acid secretion in rats: effects of NO donors and NO synthase inhibitor," *Br J Pharmacol*, vol. 123, pp. 839-846, 1998.
C. J. Hawkey and D. S. Rampton, "Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment?" *Gastroenterol*, vol. 89, pp. 1162–1188, 1985.
H. Asako, P. Kubes, J. L. Wallace, R. E. Wolf, and D. N. Granger, "Modulation of leukocyte adhesion in rat mesenteric venules by aspirin and salicylate," *Gastroenterol*, vol.
Hogaboam CM, Bissonnette EY, Chin BC, Befus AD, Wallace JL. Prostaglandins inhibit inflammatory mediator release from rat mast cells. Gastroenterology. 1993;104:122–129.
Kunkel SL, Spengler M, May MA, Spengler R, Larrick J, Remick D. Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem. 1988;263:5380–5384.
Wong K, Freund F. Inhibition of n-formylmethiony-leucyl- phenylalanine induced respiratory burst in human neutrophils by adrenergic agonists and prostaglandins of the E series. Can J Physiol Pharmacol. 1981;59:915–920.
Whittle BJR, Oren-Wolman N, Guth PH. Gastric vasoconstrictor actions of leukotriene C4, PGF2 alpha, and thromboxane mimetic U- 46619 on rat submucosal microcirculation in vivo. Am J Physiol. 1985;248:580-586.
Goldberg MM, Subers EM. The reactivity of rat isolated gastrointestinal tissues to leukotrienes. Eur J Pharmacol. 1982;78:463-466.
Peck MJ, Piper PJ, Williams TJ. The effect of leukotrienes C4 and D4 on the microvasculature of the guinea pig skin. Prostaglandins. 1981;21:315-321.
Peskar BM, Lange K, Hoppe H, Peskar BA. Ethanol stimulates formation of Leukotriene C4 in rat gastric mucosa. Prostaglandins. 1986;31:283-293.
Wallace JL, MacNaughton WK, Morris GP, Beck PL. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology. 1989;96:29-36.
Yoshida N, Takemura T, Granger DN, Anderson DC, Wolf RE, McIntire LV et al. Molecular determinants of aspirin-induced neutrophil adherence to endothelial cells. Gastroenterology. 1993;105:715–724.
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
Pihan G, Rogers C, Szabo S. Vascular injury in acute gastric mucosal damage: mediatory role in leukotrienes. Dig Dis Sci. 1988;33:625-632.
Rosam AC, Wallace JL, Whittle BJR. Potent ulcerogenic actions of platelet-activating factor on the stomach. Nature. 1986;319:54-56.
Whittle BJR, Kauffman GL, Moncada S. Vasoconstriction with thromboxane A2 induces ulceration of the gastric mucosa. Nature. 1981;292:472-474.
Levi S, et al. Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferaton associated with gastric ulcer healing. Lancet. 1990;336(8719):840-843.
Sánchez-Fidalgo S, et al. Angiogenesis, cell proliferation and apoptosis in gastric ulcer healing. Effect of a selective cox-2 inhibitor. Eur J Pharmacol. 2004;505(1-3):187-194.
Blandizzi C, et al. Clinical efficacy of esomeprazole in the prevention and healing of gastrointestinal toxicity associated with NSAIDs in elderly patients. Drugs Aging. 2008;25(3):197-208.
Blandizzi C, et al. Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy. Pharmacol Res. 2009;59(2):90-100.
Bias P, et al. The gastrointestinal tolerability of the LOX/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: results from a randomized, controlled trial. Am J Gastroenterol. 2004;99(4):611-618.
Becker JC, et al. Current approaches to prevent NSAID-induced gastropathy--COX selectivity and beyond. Br J Clin Pharmacol. 2004;58(6):587-600.
Anand BS, et al. Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects. Am J Gastroenterol. 1999;94(7):1818-1822.
Lanza FL, et al. Clinical trial: comparison of ibuprofen-phosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients. Aliment Pharmacol Ther. 2008;28(4):431-442.
Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik JM. Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med. 2009;169:515-523.
Wang FM, Xu G, Zhang Y, Ma LL. Red cell distribution width is associated with presence, stage, and grade in patients with renal cell carcinoma. Dis Markers. 2014;2014:860419.
Peng YF, Cao WY, Zhang Q, Chen D, Zhang ZX. Assessment of the Relationship Between Red Cell Distribution Width and Multiple Sclerosis. Medicine (Baltimore). 2015;94:e1182.
Peng YF, Zhang Q, Cao L, et al. Red blood cell distribution width: a potential maker estimating disease activity of ankylosing spondylitis. Int J Clin Exp Med. 2014;7:5289-5295.
Tseliou E, Terrovitis JV, Kaldara EE, et al. Red blood cell distribution Width is a significant prognostic marker in advanced heart failure, Independent of hemoglobin levels. Hellenic J Cardiol. 2014;55:457-461.
Akkermans MD, Vreugdenhil M, Hendriks DM, et al. Iron Deficiency in Inflammatory Bowel Disease: The use of Zinc protoporphyrin and Red Blood Cell Distribution Width. J Pediatr Gastroenterol Nutr. 2016;Sep 12 [Epub ahead of print].
Caglar Bilgin B, Kahramanca S, Akin T, Emre Gokce I, Akin M, Kucukpinar T. Factors influencing cost, length of hospital stay and mortality in colorectal cancer. J BUON. 201
Liu S, Wang P, Shen PP, Zhou JH. Predictive values of red blood cell distribution width in assessing severity of chronic heart failure. Med Sci Monit. 2016;22:2119-2125. PMID: 27324271.
Khawar MB, Abbasi MH, Sheikh N. IL-32: A novel pluripotent inflammatory interleukin, towards gastric inflammation, gastric cancer, and chronic rhinosinusitis. Mediators Inflamm. 2016;2016:8413768. PMID: 27143819.
Voudoukis E, Karmiris K, Oustamanolakis P, et al. Association between thrombocytosis and iron deficiency anemia in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2013;25:1212-1216. PMID: 23839158.
Akkermans MD, Uijterschout L, Lemans J, et al. Red blood cell distribution width and the platelet count in iron-deficient children aged 0.5-3 years. Pediatr Hematol Oncol. 2015;32:624-632. PMID: 26558306.
Sipponen P, Maroons HI. Chronic gastritis. Scand J Gastroenterol. 2015;50:657-667. PMID: 25901896.
Copyright (c) 2024 Wafaa Abdulmutalib Naji , Sheereehan Abdullhussein Albyati, Walaa Najah Majid
This work is licensed under a Creative Commons Attribution 4.0 International License.
